Khoo SH, FitzGerald R, Saunders G, et al. Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Infect Dis 2022; published online Oct 19. https://doi.org/10.1016/S1473-3099(22)00644-2—In this Article, the AGILE CST-2 Study Group list has been updated. This correction has been made to the online version as of Nov 14, 2022, and will be made to the printed version.
. 2022 Nov 14;23(1):e1. doi: 10.1016/S1473-3099(22)00740-X
Correction to Lancet Infect Dis 2022; published online Oct 19. https://doi.org/10.1016/S1473-3099(22)00644-2
Issue date 2023 Jan.
© 2022 The Author(s). Published by Elsevier Ltd.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9662829 PMID: 36395780